Integer to Showcase Innovative Miniaturized Devices at NANS 2025
Integer Holdings Corporation (NYSE: ITGR), a leader in the medical device contract development and manufacturing sector, is set to make a significant impact at the upcoming North American Neuromodulation Society (NANS) Annual Meeting. This important event will take place in a vibrant city and is expected to draw numerous industry professionals eager to learn about the latest advancements in neuromodulation from January 30 to February 1.
Visit Integer at NANS Annual Meeting
Attendees of the NANS Annual Meeting are encouraged to stop by Integer's booth #213 to explore how the company can serve as an essential strategic partner. This presence at NANS underscores Integer's commitment to helping its customers elevate their innovation processes and enhance their time to market for groundbreaking medical devices.
Focus on Neuromodulation Innovations
Integer plans to exhibit its state-of-the-art advancements in neuromodulation, highlighting the company's capabilities in creating the next generation of miniaturized active implantable medical devices (AIMDs). These devices are critical in providing solutions for various medical challenges and improving patient outcomes.
Expert Insights from Integer Leaders
Jim Stephens, President of Cardiac Rhythm Management & Neuromodulation at Integer, emphasized, "Through miniaturization, we are pioneering differentiated platform technologies that streamline and mitigate risks for OEMs pursuing novel implantable medical technologies. Our vast knowledge in essential implantable technologies, including advanced battery designs and integrated pulse generator systems, positions us uniquely in this field. We eagerly await the opportunity to share our insights and advancements at NANS."
Introducing Xcellion Gen 3 Fast Charge Technology
As part of its showcase, Integer will feature the Xcellion Gen 3 Fast Charge Lithium Ion implantable battery technology. This innovative battery not only promises leading runtime performance but can also achieve full recharging in as little as 30 minutes—a remarkable advancement that can significantly enhance the functionality of implantable devices.
About Integer Holdings Corporation
Integer Holdings Corporation, trading under NYSE: ITGR, holds a prestigious position in the medical device CDMO landscape, serving vital markets including cardiac rhythm management and neuromodulation. The company's unwavering commitment to enhancing the wellbeing of patients worldwide is reflected in its high-quality products and pioneering solutions.
Integer collaborates closely with medical device companies and OEMs, bringing innovative concepts to fruition. With brands like Greatbatch Medical and Lake Region Medical under its umbrella, Integer exemplifies industry leadership and dedication. For more detailed information about Integer’s offerings and initiatives, please visit their official website.
Frequently Asked Questions
What is NANS 2025?
NANS 2025 is the annual meeting of the North American Neuromodulation Society, where leaders in the field gather to share insights and advancements.
What innovations will Integer showcase?
Integer will exhibit its next-generation miniaturized active implantable medical devices and advanced battery technologies.
Where can I find Integer's booth at NANS?
Integer will be located at booth #213 during the NANS Annual Meeting.
What is the Xcellion Gen 3 technology?
Xcellion Gen 3 is an implantable battery technology that provides excellent runtime and fast recharging capabilities.
How can I learn more about Integer Holdings?
For more information on Integer Holdings Corporation, visit their official website or contact their investor and media relations.
